Multiple Myeloma News
Semistructured Patient Interviews Identify Facilitators of MM Treatment Initiation, Continuation
Source: Myeloma - Hematology Advisor Researchers identified 3 factors that encourage patients with MM to initiate and continue their treatment over the long term. Read More
CAR-T Therapy May Help Slow Multiple Myeloma Progression
Source: Myeloma - Hematology Advisor Researchers sought to determine whether CAR-T therapy with cilta-cel would slow progression of multiple myeloma. Read More
Dual Bispecific Combination Study Shows 96% Overall Response Rate in Relapsed/Refractory Multiple Myeloma
Source: Pharmacy Times articles Findings highlight the potential efficacy of combining 2 novel bispecific therapies, teclistamab-cqyv and talquetamab, which target distinct antigens on myeloma cells. Read More
Belamaf Yields Comparable PFS vs Pomalidomide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
Source: Myeloma - Hematology Advisor Researchers sought to determine whether belamaf would improve PFS rates compared with Pd among patients with relapsed/refractory multiple myeloma. Read More
Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma
Source: Myeloma : nature.com subject feeds Post Content Read More
Pharmacoscopy Platform Creates Automated, Personalized Selection of Treatment Options for Patients With Multiple Myeloma
Source: Pharmacy Times articles Multiple myeloma treatment selection is critical due to the potential for developing treatment resistance over time to the currently prescribed drugs. Read More
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
Source: Myeloma : nature.com subject feeds Post Content Read More
IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma
Source: Myeloma : nature.com subject feeds Post Content Read More
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
Source: Myeloma : nature.com subject feeds Post Content Read More
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma
Source: Myeloma : nature.com subject feeds Post Content Read More